SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001638599-20-000828
Filing Date
2020-09-24
Accepted
2020-09-24 19:29:37
Documents
1
Period of Report
2020-09-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3_6878.html 3  
1 PRIMARY DOCUMENT doc3_6878.xml 3 1507
  Complete submission text file 0001638599-20-000828.txt   2944
Mailing Address 860 WASHINGTON STREET 10TH FLOOR NEW YORK NY 10014
Business Address
Neu Kelvin (Reporting) CIK: 0001554699 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39527 | Film No.: 201196505

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations